Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses

por Kringel, D, Ultsch, A, Zimmermann, M, Jansen, J-P, Ilias, W, Freynhagen, R, Griessinger, N, Kopf, A, Stein, C, Doehring, A, Resch, E, Lötsch, J
Publicado 2017